Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04803123
Title Window Trial to Evaluate Molecular Response to PI3K Inhibition With Copanlisib in r/r Adult B-cell ALL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dorothy Sipkins, MD, PhD
Indications

B-cell adult acute lymphocytic leukemia

Therapies

Copanlisib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.